| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07430800 Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety |
date change Primary completion moved earlier: 2028-08 -> 2028-02-14 |
| 2026-06-04 | NCT03344211 Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic… |
date change Primary completion pushed: 2026-11-21 -> 2026-12-31 |
| 2026-06-04 | NCT03344211 Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic… |
date change Completion pushed: 2027-11-21 -> 2027-12-31 |
| 2026-06-02 | NCT04981834 Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate… |
date change Primary completion pushed: 2026-03-31 -> 2027-03-31 |
| 2026-06-02 | NCT04981834 Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate… |
date change Completion pushed: 2026-03-31 -> 2027-03-31 |
| 2026-06-02 | NCT06129123 An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young… |
Trial completed |
| 2026-06-02 | NCT05791448 AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver… |
date change Primary completion pushed: 2026-03-29 -> 2027-03-29 |
| 2026-06-02 | NCT05791448 AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver… |
date change Completion pushed: 2027-03-29 -> 2028-03-29 |
| 2026-05-30 | NCT07244211 MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After… |
Trial sites expanded: 9 -> 12 locations |
| 2026-05-20 | NCT05989828 A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1… |
date change Primary completion pushed: 2026-12-17 -> 2027-12-31 |
| 2026-05-20 | NCT05989828 A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1… |
date change Completion pushed: 2027-12-17 -> 2028-12-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07631130 Home and Community Use of a Suspension Walker in Pre-Walking Infants With Down Syndrome | Not Yet Recruiting | |
| 2026-06-03 | NCT07624292 An Online Intervention to Reduce E-cigarette Use and Cigarette Smoking Risk in Adolescents | Not Yet Recruiting | |
| 2026-05-22 | NCT07602699 Multi-Site Trial of Tirzepatide for Smoking Cessation | Phase 2 | Recruiting |
| 2026-05-14 | NCT07587619 Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion | Phase 1/2 | Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05746143 | The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion | Spine Fusion | Recruiting |
| NCT06701071 | Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation | Infertility, Female | Recruiting |
| Phase 3 | |||
| NCT04958122 | Cefixime Clinical Trial | Syphilis | Recruiting |
| Phase 2 | |||
| NCT04460573 | Smart Boot Use to Measure Offloading Adherence | Diabetic Foot Ulcer | Recruiting |
| NCT06063486 | Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of… | Clonal Cytopenia of Undetermined Significance | Recruiting |
| NCT06345859 | Regulation of Affect and Physiology in Depression | Major Depressive Disorder | Recruiting |
| NCT07602699 | Multi-Site Trial of Tirzepatide for Smoking Cessation | Smoking Cessation | Recruiting |
| NCT06419985 | Ketamine HCl Prolonged Release Oral Tablets for CRPS | Complex Regional Pain Syndromes | Not Yet Recruiting |
| NCT05340309 | Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| NCT05548426 | Linezolid for Syphilis Pilot Study | Syphilis | Active, Not Recruiting |
| NCT05644262 | Life's End Benefits of cannaBidiol and tetrahYdrocannabinol | Agitation | Active, Not Recruiting |
| NCT07447206 | Vascular Intervention Strategies Trial for Alzheimer's | Hypertension | Not Yet Recruiting |
| NCT04315701 | A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or… | Recurrent Skin Squamous Cell Carcinoma | Active, Not Recruiting |
| NCT03092856 | Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With… | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| NCT03344211 | Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT02717156 | Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors | Stage IV Bladder Urothelial Carcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07210775 | Topical Imiquimod Treatment of Oral Dysplasia | Oral Dysplasia | Recruiting |
| NCT04333706 | A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic… | Breast | Recruiting |
| NCT02935361 | Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic… | Chronic Myelomonocytic Leukemia | Active, Not Recruiting |
| NCT05514990 | Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or… | Recurrent Plasma Cell Myeloma | Active, Not Recruiting |
| NCT07587619 | Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion | Colorectal Cancer | Active, Not Recruiting |
| NCT03330821 | Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Active, Not Recruiting |
| Phase 1 | |||
| NCT06171607 | Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses | Breast Carcinoma | Recruiting |
| NCT06336902 | Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With… | Metastatic Colorectal Adenocarcinoma | Recruiting |
| NCT05989828 | A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1… | Triple Negative Breast Cancer | Recruiting |